Human FIX Inhibitor, frozen. Mild inhibitor potency (1-10 BU/mL). Plasma Factor Inhibitor Plasmas are produced from normal human plasmas from which specific factors have been removed by selective affinity immuno-adsorption and an antibody inhibitory to the specific factor is added to provide neutralizing activity. These products can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors and can be used as positive controls in factor inhibitor assays. The inhibitor potency is measured by standard Bethesda activity assay.
Learn more about Factor IX
Related Products
| Reference | Product name | Packaging | Categories |
| 221801 | BIOPHEN™ Factor IX - small | 2 x 20 tests | Chromogenic Assay |
| 221802 | BIOPHEN™ Factor IX - medium | 2 x 50 tests | Chromogenic Assay |
| 221806 | BIOPHEN™ Factor IX - large | 2 x 120 tests | Chromogenic Assay |
| 221812 | BIOPHEN™ Factor IXa | 2 x 50 tests | Chromogenic Assay |
| RK032A | ZYMUTEST™ Factor IX | 96 tests | ELISA |
| 222101 | BIOPHEN™ Plasma Calibrator | 12 x 1ml | Calibrator |
| 223201 | BIOPHEN™ Normal Control Plasma | 12 x 1ml | Control |
| 223301 | BIOPHEN™ Abnormal Control Plasma | 12 x 1ml | Control |
| 224601 | BIOPHEN™ FIXa Control set | 2x (6x1ml) | Control |
| 5D-44206A | 5-CONTROL Factor IXa positive control for NaPTT, 10 | 10mIU | Control |
| 5D-44206B | 5-CONTROL Factor IXa positive control for NaPTT, 20 | 20mIU | Control |
| AR026A | Special Tris-BSA buffer (for BIOPHEN™ VIII:C, FIX, FIXa) | 3 x 25ml | Auxiliary Reagent |
| AR026K | Special Tris-BSA buffer (for BIOPHEN™ VIII:C, FIX, FIXa) | 12 x 25ml | Auxiliary Reagent |
| DP050A | Factor IX Deficient Plasma - Small | 1ml | Deficient Plasma |
| DP050K | Factor IX Deficient Plasma - large | 6 x 1ml | Deficient Plasma |
| 5D-47113F | Human Factor IX Inhibitor Plasma, Mild, Frozen | 1mL | Inhibitor Plasma |
| 5D-47113L | Human Factor IX Inhibitor Plasma, Mild, Lyophilized | 1mL | Inhibitor Plasma |
Antibodies Chromogenic Substrates Purified Proteins
